Mostrando resultados 113 a 132 de 163
< Anterior
Siguiente >
| Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
| closedAccess |  | 2010 | P53 deletion may drive the clinical evolution and treatment response in multiple myeloma | López-Anglada, Lucía; Gutiérrez, Norma Carmen; García, Juan L. CSIC ORCID CVN ; Mateos, Maria Victoria; Flores, Teresa; San Miguel, Jesús F. CSIC ORCID | artículo |
| openAccess |  | 2015 | Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study | Ocio, Enrique M. CSIC ORCID ; Pérez-Simón, José A. CSIC ORCID; Chillón, M. del Carmen; Díez-Campelo, María; González, Marcos CSIC ORCID ; Vidriales, Maria Belén; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2019 | Pembrolizumab combined with lenalidomide and low‐dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE‐023 study | Mateos, Maria Victoria; Orlowski, R. Z.; Ocio, Enrique M. CSIC ORCID ; Rodríguez-Otero, Paula; Reece, Donna; Moreau, Philippe; Munshi, Nikhil; Avigan, David E.; Siegel, David S.; Ghori, Razi; Farooqui, Mohammed Z. H.; Marinello, Patricia; San Miguel, Jesús F. CSIC ORCID | artículo |
| openAccess |  | 2013 | Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma | San Miguel, Jesús F. CSIC ORCID; Dimopoulos, Meletios A.; Palumbo, Antonio; Delforge, Michel; Mateos, Maria Victoria; Richardson, Paul G. | artículo |
| closedAccess |  | 2011 | Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN) | Palumbo, Antonio; Bladé, Joan; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID | artículo |
| openAccess |  | feb-2023 | Phase 1b Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed, Transplant-ineligible Multiple Myeloma Patients | Ocio, Enrique M. CSIC ORCID ; Bringhen, Sara; Martínez-López, Joaquín; San-Miguel, Jesús; Oliva, Stefania; Rodríguez-Otero, Paula; Le Roux, Nadia; Dong, Yvonne; Doroumian, Severine; Macé, Sandrine; Mateos, Maria Victoria | editorial |
| closedAccess |  | 2015 | Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential | Paíno, Teresa CSIC ORCID; Paiva, Bruno; Sayagués, José María CSIC ORCID ; Corchete, Luis A.; Bárcena, Paloma; Ocio, Enrique M. CSIC ORCID ; San-Segundo, Laura CSIC; Sarasquete, María Eugenia; García-Sanz, Ramón; Vidriales, Maria Belén; Paiva, Artur; Bladé, Joan; Lahuerta, Juan José; Orfao, Alberto CSIC ORCID ; Mateos, Maria Victoria; Gutiérrez, Norma Carmen; Hernández, Mª Teresa; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2016 | Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis | Paiva, Bruno; Martínez-López, Joaquín; Corchete, Luis A.; Sanchez-Vega, Beatriz; Rapado, Inmaculada; Puig, Noemi; Barrio, Santiago; Sánchez, Maria Luz; Alignani, Diego; Lasa, Marta; García de Coca, Alfonso; Pardal, Emilia; Oriol, Albert; González García, María-Esther; Escalante, Fernando; González-López, Tomás J.; Palomera, Luis; Alonso, José M. CSIC; Prósper, Felipe; Orfao, Alberto CSIC ORCID ; Vidriales, Maria Belén; Mateos, Maria Victoria; Lahuerta, Juan José; Gutiérrez, Norma Carmen; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2011 | Practical management of adverse events in multiple myeloma: Can therapy be attenuated in older patients? | Palumbo, Antonio; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID | artículo |
| openAccess |  | 2017 | Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair | López-Iglesias, Ana-Alicia; Herrero, Ana B. CSIC ORCID; Chesi, Marta; San-Segundo, Laura CSIC; González-Méndez, Lorena; Hernández-García, Susana CSIC; Misiewicz-Krzeminska, Irena; Quwaider, Dalia; Martín-Sánchez, Montserrat; Primo, Daniel; Paíno, Teresa CSIC ORCID; Bergsagel, P. Leif; Mehrling, Thomas; González, Marcos CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID; Mateos, Maria Victoria; Gutiérrez, Norma Carmen; Garayoa, Mercedes CSIC ORCID ; Ocio, Enrique M. CSIC ORCID | artículo |
| openAccess |  | 2020 | Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma | Algarín, Esperanza M.; Díaz-Tejedor, Andrea; Mogollón, Pedro; Hernández-García, Susana CSIC; Corchete, Luis A.; San-Segundo, Laura CSIC; Martín-Sánchez, Montserrat; González-Méndez, Lorena; Schoumacher, Marie; Banquet, Sebastien; Kraus-Berthie, Laurence; Kloos, Ioana; Derreal, Alix; Halilovic, Ensar; Maacke, Heiko; Gutiérrez, Norma Carmen; Mateos, Maria Victoria; Paíno, Teresa CSIC ORCID; Garayoa, Mercedes CSIC ORCID ; Ocio, Enrique M. CSIC ORCID | carta al director |
| closedAccess |  | 2017 | Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array | García-Sanz, Ramón; Corchete, Luis A.; Alcoceba, Miguel; Chillón, M. del Carmen; Jiménez, Cristina; Prieto-Conde, Isabel; García-Alvarez, María; Puig, Noemi; Rapado, Inmaculada; Barrio, Santiago; Oriol, Albert; Blanchard, María Jesús; Rubia, Javier de la; Martínez, Rafael; Lahuerta, Juan José; González, Marcos CSIC ORCID ; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID; Martínez-López, Joaquín; Sarasquete, María Eugenia | artículo |
| openAccess |  | 2021 | Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage | Fernández de Larrea, Carlos; Kyle, Robert; Rosiñol, Laura; Paiva, Bruno; Engelhardt, Monika; Usmani, Saad Z.; Caers, Jo; Gonsalves, Wilson; Schjesvold, Fredrik; Merlini, Giampolo; Lentzsch, Suzanne; Ocio, Enrique M. CSIC ORCID ; Garderet, Laurent; Moreau, Philippe; Sonneveld, Pieter; Badros, Ashraf; Gahrton, Gösta; Goldschmidt, Hartmut; Tuchman, Sascha; Einsele, Hermann; Durie, B.; Wirk, Baldeep; Musto, Pellegrino; Hayden, Patrick; Kaiser, Martin; San-Miguel, Jesús; Bladé, Joan; Rajkumar, S. Vincent; Mateos, Maria Victoria | artículo |
| openAccess |  | ago-2022 | Prognostic Stratification of Multiple Myeloma Using Clinicogenomic Models: Validation and Performance Analysis of the IAC-50 Model | Mosquera Orgueira, Adrián; González Pérez, Marta Sonia; Díaz Arias, José; Antelo Rodríguez, Beatriz; Mateos, Maria Victoria | artículo |
| openAccess |  | 2018 | Prognostic value of antigen expression in multiple myeloma: a PETHEMA/GEM study on 1265 patients enrolled in four consecutive clinical trials | Arana, Paula; Paiva, Bruno; Cedena, Maria-Teresa; Puig, Noemi; Cordón, Lourdes; Vidriales, Maria Belén; Gutiérrez, Norma Carmen; Chiodi, Francesca; Burgos, Leire; Anglada, Lucia-Lopez; Martínez-López, Joaquín; Hernandez, Miguel T.; Teruel, Ana-Isabel; Gironella, Mercedes; Echeveste, María-Asunción; Rosiñol, Laura; Martínez, Rafael; Oriol, Albert; Rubia, Javier de la; Orfao, Alberto CSIC ORCID ; Bladé, Joan; Lahuerta, Juan José; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2014 | Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma | Martínez-López, Joaquín; Lahuerta, Juan José; González, Marcos CSIC ORCID ; Paiva, Bruno; Jiménez, Cristina; Mateos, Maria Victoria; Bladé, Joan; García-Sanz, Ramón | artículo |
| closedAccess |  | 10-feb-2022 | Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, and MAIA | Cavo, Michele; San-Miguel, Jesús; Usmani, Saad Z.; Weisel, Katja C.; Dimopoulos, Meletios A.; Avet-Loiseau, Hervé; Paiva, Bruno; Bahlis, Nizar J.; Plesner, Torben; Hungria, Vania; Moreau, Philippe; Mateos, Maria Victoria; Perrot, Aurore; Iida, Shinsuke; Facon, Thierry; Kumar, Shaji; Donk, Niels W. C. J. van de; Sonneveld, Pieter; Spencer, Andrew; Krevvata, Maria; Heuck, Christoph; Wang, Jianping; Ukropec, Jon; Kobos, Rachel; Sun, Steven; Qi, Mia; Munshi, Nikhil | artículo |
| openAccess |  | 24-sep-2020 | Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma | Paíno, Teresa CSIC ORCID; González-Méndez, Lorena; San-Segundo, Laura CSIC; Corchete, Luis A.; Hernández-García, Susana CSIC; Díaz-Tejedor, Andrea; Algarín, Esperanza M.; Mogollón, Pedro; Martín-Sánchez, Montserrat; Gutiérrez, Norma Carmen; Mateos, Maria Victoria; Garayoa, Mercedes CSIC ORCID ; Ocio, Enrique M. CSIC ORCID | artículo |
| openAccess |  | 8-dic-2020 | Quantitative expression of Ikaros, IRF4, and PSMD10 proteins predicts survival in VRD-treated patients with multiple myeloma | Misiewicz-Krzeminska, Irena; Ramón, Cristina de; Corchete, Luis A.; Krzemiński, Patryk; Rojas, Elizabeta A. CSIC ORCID; Isidro, Isabel; García-Sanz, Ramón; Martínez-López, Joaquín; Oriol, Albert; Bladé, Joan; Lahuerta, Juan José; Miguel, Jesus F. San; Rosiñol, Laura; Mateos, Maria Victoria; Gutiérrez, Norma Carmen | artículo |
| openAccess | | oct-2023 | Randomized phase II study of weekly carfilzomib 70 mg/m2 and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients | Puertas Martínez, Borja; González-Calle, Verónica; Sureda, Anna; Moreno, María José; Oriol, Albert; González, Esther; Rosiñol, Laura; López, Jordi; Escalante, Fernando; Martínez-López, Joaquín; Carrillo Cruz, Estrella; Clavero, Esther; Ríos-Tamayo, R.; Rey-Bua, Beatriz; Gonzalez-Rodriguez, Ana Pilar; Dourdil, Mª Victoria; Arriba, Felipe de; González, Sonia; Pérez de Oteyza, Jaime; Hernandez, Miguel T.; García-Mateo, Aránzazu; Bargay, Joan; Bladé, Joan; Lahuerta, Juan José; San Miguel, Jesús F. CSIC ORCID; Ocio, Enrique M. CSIC ORCID ; Mateos, Maria Victoria | artículo |
